US 11,752,219 B2
Substrate delivery of embedded liposomes
Srivatsan Kidambi, Lincoln, NE (US); and Stephen L. Hayward, Lincoln, NE (US)
Assigned to NUtech Ventures, Lincoln, NE (US)
Filed by NUtech Ventures, Lincoln, NE (US)
Filed on Nov. 2, 2021, as Appl. No. 17/517,360.
Application 17/517,360 is a continuation of application No. 15/752,668, granted, now 11,202,838, previously published as PCT/US2016/047042, filed on Aug. 15, 2016.
Claims priority of provisional application 62/205,473, filed on Aug. 14, 2015.
Prior Publication US 2022/0226498 A1, Jul. 21, 2022
Int. Cl. A61K 47/69 (2017.01); A61K 9/127 (2006.01); A61K 47/61 (2017.01); A61K 31/704 (2006.01); A61K 47/34 (2017.01); C12N 15/113 (2010.01)
CPC A61K 47/6911 (2017.08) [A61K 9/1272 (2013.01); A61K 31/704 (2013.01); A61K 47/34 (2013.01); A61K 47/61 (2017.08); C12N 15/1135 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method of treating a disease in a subject in need thereof, comprising administering to the subject a composition comprising:
i) one or more hyaluronic acid conjugated liposomes; and
ii) a polyelectrolyte multilayer, and
wherein the liposome comprises one or more therapeutic agents.